Systemic immune and stromal cells outside the liver

Systemic immune and stromal cells outside the liver encompass the diverse array of leukocytes and connective tissue cells located in the blood, lymph nodes, spleen, and peripheral organs. This classification includes T cells, B cells, macrophages, and dendritic cells, as well as stromal elements like fibroblasts and vascular endothelial cells (Janeway's Immunobiology, 2016). These cells are fundamental to the body's defense against pathogens and the maintenance of tissue architecture throughout the organism. They also serve as the primary mediators of systemic autoimmune and inflammatory diseases, such as rheumatoid arthritis and systemic lupus erythematosus (Nature Reviews Immunology, 2021). In drug development, this compartment is frequently analyzed to determine the systemic impact and safety profile of therapies, particularly when assessing the off-target effects of liver-directed treatments like siRNA or antisense oligonucleotides (Nucleic Acids Research, 2018). For instance, GalNAc-conjugated drugs are designed to minimize interaction with these systemic cells to reduce extrahepatic toxicity. Because this entry describes a broad physiological compartment rather than a single molecular entity, it is not classified as a discrete therapeutic target.

Other names

Extrahepatic immune and stromal compartmentPeripheral immune systemSystemic stromaNon-hepatic immune cells

Drugs interacting with this compartment typically act through systemic immunosuppression, inhibition of cytokine signaling, or modulation of leukocyte trafficking and stromal cell activation.